• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
HVN
Click for more information
0.00% $4.92

HARVEY NORMAN HOLDINGS LIMITED - Charts / Financials

Market Cap $6.130B  ! watchlist Created with Sketch. Add to my watchlist

Harvey Norman Holdings Limited is an Australia-based company engaged in the integrated... Harvey Norman Holdings Limited is an Australia-based company engaged in the integrated retail, franchise, property and digital system business. Its principal activities include franchisor; sale of furniture, bedding, computers, communications and consumer electrical products in New Zealand, Singapore, Malaysia, Slovenia, Ireland, Northern Ireland and Croatia; property investment; lessor of premises to Harvey Norman, Domayne and Joyce Mayne franchisees and other third parties; media placement, and provision of consumer finance and other commercial loans and advances. Its segments include Franchising Operations, Retail-New Zealand, Retail-Singapore & Malaysia, Retail-Slovenia & Croatia, Retail-Ireland & Northern Ireland, Other Non-Franchised Retail, Retail Property, Retail Property Under Construction, Property Developments for Resale, Equity Investments, and Other. Its brands sell products under various categories, including electrical goods, furniture, and computerized communications.More

refresh Created with Sketch. REFRESH
Last update - 10.16am 02/10/2024 (20 minute delay) ?
Day
Open 0.0¢   Day High 0.0¢   Day Low 0.0¢
Daily Volume 0
Bids   Sellers
Number Price Volume   Number Price Volume
11 $5.90 5671   2 $4.56 23

Directors & Senior Management

Mr. Gerald Harvey Executive Chairman of the Board
Ms. Kay Lesley Page Chief Executive Officer, Executive Director
Mr. Chris Mentis Chief Financial Officer, Company Secretary, Executive Director
Mr. John Evyn Slack-Smith Chief Operating Officer, Executive Director
Mr. Gordon Ian Dingwall Chief Information Officer
Mr. Christopher Coen General Manager - Home Appliances
Mr. Benjamin Kelada General Manager - Audio Visual
Ms. Carene Myers General Manager - Small Appliances
Mr. Haydon Ian Myers General Manager - Electrical
Mr. Darren Salakas General Manager - Technology & Entertainment
Mr. Christopher Herbert Brown Non-Executive Director
Mr. Michael John Harvey Non-Executive Director
Ms. Luisa Catanzaro Non-Executive Independent Director
Mr. Maurice John Craven Non-Executive Independent Director
Mr. Kenneth William Gunderson Briggs Non-Executive Independent Director

Data source: Refinitiv

(20min delay)
Last
$4.92 		Change
0.000(0.00%) 		Mkt cap ! $6.130B
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0

Buyers (Bids)

No. Vol. Price($)
11 5671 $5.90
 

Sellers (Offers)

Price($) Vol. No.
$4.56 23 2
View Market Depth
Last trade - 09.57am 02/10/2024 (20 minute delay) ?
Last
$4.93 		  Change
0.000 ( 0.13 %)
Open High Low Volume
$4.93 $4.93 $4.92 11696
Last updated 10.16am 02/10/2024 ?

Top Stories

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Coda Minerals (ASX:COD) CEO, Chris Stevens, joins The Market Online to discuss the company's current rights issue, and how the capital from this raise will be used to further its copper exploration in South Australia. In addition, Chris talks through the journey the company has taken over the last few years since listing until now.
Canada orders national security review over CGN's 11.26% opposition to Paladin-Fission deal Paladin has disclosed its attempted takeover of Fission Uranium Corp was blocked by a Chinese shareholder late last month.
Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals Actinogen Medical is developing a promising oral treatment for Alzheimer's and depression and is accelerating clinical trials with new capital.
Firebird achieves preliminary approvals for its Jinshi plant design Firebird Metals Ltd has reached a significant stage in development of its battery-grade manganese sulphate plant in China
Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger Recce Pharmaceuticals (ASX:RCE) has been on a tear this year. It's developing anti-infective, R327, with clinical results across Diabetic Foot Infection, Acute Bacterial Skin & Skin Structure Infection, and, Urosepsis/UTIs which point to a potential commercial value proposition. It also has a recent key relationship in Indonesia.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.